The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Cell factories for insulin production
Open accessAbstract
The rapid increase in the number of diabetic patients globally and exploration of alternate insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound to escalate the demand for recombinant insulin in near future. Current manufacturing technologies would be unable to meet the growing demand of affordable insulin due to limitation in production capacity and high production cost. Manufacturing of therapeutic recombinant proteins require an appropriate host organism with efficient machinery for posttranslational modifications and protein refolding. Recombinant human insulin has been produced predominantly using E. coli and Saccharomyces cerevisiae for therapeutic use in human. We would focus in this review, on various approaches that can be exploited to increase the production of a biologically active insulin and its analogues in E. coli and yeast. Transgenic plants are also very attractive expression system, which can be exploited to produce insulin in large quantities for therapeutic use in human. Plant-based expression system hold tremendous potential for high-capacity production of insulin in very cost-effective manner. Very high level of expression of biologically active proinsulin in seeds or leaves with long-term stability, offers a low-cost technology for both injectable as well as oral delivery of proinsulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Construction of Biologically Functional Bacterial Plasmids In Vitro
Cohen, S. N., Chang, A. C. Y., Boyer, H. W., & Helling, R. B. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.11.3240 · Cited by 1,802
Strategies for achieving high-level expression of genes in Escherichia coli
Makrides, S. C. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.512-538.1996 · Cited by 1,276
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology by
Blundell, T., Dodson, G., Hodgkin, D., & Mercola, D. (1972) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60143-6 · Cited by 836
N-Linked Glycosylation in Campylobacter jejuni and Its Functional Transfer into E. coli
Wacker, M., Linton, D., Hitchen, P. G., Nita-Lazar, M., Haslam, S. M., North, S. J., Panico, M., Morris, H. R., Dell, A., Wren, B. W., et al. (2002) · Science · doi:10.1126/science.298.5599.1790 · Cited by 777
Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli
Kane, J. F. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80082-4 · Cited by 759
Biopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 756
Monomeric insulins obtained by protein engineering and their medical implications
Brange, J., Ribel, U., Hansen, J. F., Dodson, G., Hansen, M. T., Havelund, S., Melberg, S. G., Norris, F., Norris, K., Snel, L., et al. (1988) · Nature · doi:10.1038/333679a0 · Cited by 488
High-yield production of a human therapeutic protein in tobacco chloroplasts
Staub, J. M., Garcia, B., Graves, J., Hajdukiewicz, P. T. J., Hunter, P., Nehra, N., Paradkar, V., Schlittler, M., Carroll, J. A., Spatola, L., et al. (2000) · Nature Biotechnology · doi:10.1038/73796 · Cited by 486
Sahdev, S., Khattar, S. K., & Saini, K. S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9603-6 · Cited by 474
Self-citationMicrobial factories for recombinant pharmaceuticals
Ferrer-Miralles, N., Domingo-Espín, J., Corchero, J. L., Vázquez, E., & Villaverde, A. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-17 · Cited by 465
Bacterial expression systems for recombinant protein production: E. coli and beyond
Chen, R. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.09.013 · Cited by 459
Feldman, M. F., Wacker, M., Hernandez, M., Hitchen, P. G., Marolda, C. L., Kowarik, M., Morris, H. R., Dell, A., Valvano, M. A., & Aebi, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500044102 · Cited by 442
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin
Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 429
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements
Huang, C.-J., Lin, H., & Yang, X. (2012) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-011-1082-9 · Cited by 424
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi
Gerngross, T. U. (2004) · Nature Biotechnology · doi:10.1038/nbt1028 · Cited by 409
The humanization of N-glycosylation pathways in yeast
Wildt, S., & Gerngross, T. U. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1087 · Cited by 393
Expression of the lacZ gene from two methanol-regulated promoters in Pichia pastoris
Tschopp, J. F., Brust, P. F., Cregg, J. M., Stillman, C. A., & Gingeras, T. R. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.9.3859 · Cited by 377
Overcoming barriers to membrane protein structure determination
Bill, R. M., Henderson, P. J. F., Iwata, S., Kunji, E. R. S., Michel, H., Neutze, R., Newstead, S., Poolman, B., Tate, C. G., & Vogel, H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1833 · Cited by 373
Owens, D. R., Zinman, B., & Bolli, G. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05842-1 · Cited by 373
Monomeric Insulins and Their Experimental and Clinical Implications
Brange, J., Owens, D. R., Kang, S., & Vølund, A. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.923 · Cited by 369
Recombinant Protein Production in Yeasts
Mattanovich, D., Branduardi, P., Dato, L., Gasser, B., Sauer, M., & Porro, D. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-433-9_17 · Cited by 357
Arakawa, T., Yu, J., Chong, D. K. X., Hough, J., Engen, P. C., & Langridge, W. H. R. (1998) · Nature Biotechnology · doi:10.1038/nbt1098-934 · Cited by 279
Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering
Nielsen, J. (2013) · Bioengineered · doi:10.4161/bioe.22856 · Cited by 270
Ellis, S. B., Brust, P. F., Koutz, P. J., Waters, A. F., Harpold, M. M., & Gingeras, T. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1111 · Cited by 269
What's fueling the biotech engine—2012 to 2013
(Rob) Aggarwal, S. (2014) · Nature Biotechnology · doi:10.1038/nbt.2794 · Cited by 254
Advances in the use of Pichia pastoris for high-level gene expression
Romanos, M. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80087-5 · Cited by 248
High-Level Secretion of Glycosylated Invertase in the Methylotrophic Yeast, Pichia Pastoris
Tschopp, J. F., Sverlow, G., Kosson, R., Craig, W., & Grinna, L. (1987) · Nature Biotechnology · doi:10.1038/nbt1287-1305 · Cited by 246
Grinna, L. S., & Tschopp, J. F. (1989) · Yeast · doi:10.1002/yea.320050206 · Cited by 244
Secretion and processing of insulin precursors in yeast.
Thim, L., Hansen, M. T., Norris, K., Hoegh, I., Boel, E., Forstrom, J., Ammerer, G., & Fiil, N. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6766 · Cited by 233
Recombinant protein production in bacterial hosts
Overton, T. W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.008 · Cited by 220
Production of recombinant proteins by methylotrophic yeasts
Hollenberg, C. P., & Gellissen, G. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80028-6 · Cited by 213
Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae
Hou, J., Tyo, K. E. J., Liu, Z., Petranovic, D., & Nielsen, J. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00810.x · Cited by 211
Gellissen, G., & Hollenberg, C. P. (1997) · Gene · doi:10.1016/s0378-1119(97)00020-6 · Cited by 205
Wacker, M., Feldman, M. F., Callewaert, N., Kowarik, M., Clarke, B. R., Pohl, N. L., Hernandez, M., Vines, E. D., Valvano, M. A., Whitfield, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509207103 · Cited by 194
Production of glycoprotein vaccines in Escherichia coli
Ihssen, J., Kowarik, M., Dilettoso, S., Tanner, C., Wacker, M., & Thöny-Meyer, L. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-61 · Cited by 180
Recombinant Protein Production in Yeasts
Porro, D., Sauer, M., Branduardi, P., & Mattanovich, D. (2005) · Molecular Biotechnology · doi:10.1385/mb:31:3:245 · Cited by 179
Yeast secretory expression of insulin precursors
Kjeldsen, T. (2000) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000402 · Cited by 176
Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs
Vajo, Z., Fawcett, J., & Duckworth, W. C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0442 · Cited by 172
Boyhan, D., & Daniell, H. (2011) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00582.x · Cited by 165
Nykiforuk, C. L., Boothe, J. G., Murray, E. W., Keon, R. G., Goren, H. J., Markley, N. A., & Moloney, M. M. (2006) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2005.00159.x · Cited by 163
Therapeutic insulins and their large-scale manufacture
Walsh, G. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1809-x · Cited by 161
Porro, D., Gasser, B., Fossati, T., Maurer, M., Branduardi, P., Sauer, M., & Mattanovich, D. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-3019-z · Cited by 144
Production of Secretory and Extracellular N-Linked Glycoproteins inEscherichia coli
Fisher, A. C., Haitjema, C. H., Guarino, C., Çelik, E., Endicott, C. E., Reading, C. A., Merritt, J. H., Ptak, A. C., Zhang, S., & DeLisa, M. P. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01901-10 · Cited by 134
Research, Development, Production, and Safety of Biosynthetic Human Insulin
Chance, R. E., & Frank, B. H. (1993) · Diabetes Care · doi:10.2337/diacare.16.3.133 · Cited by 126
de Marco, A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.400 · Cited by 126
Gurramkonda, C., Polez, S., Skoko, N., Adnan, A., Gäbel, T., Chugh, D. A., Swaminathan, S., Khanna, N., Tisminetzky, S. G., & Rinas, U. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-31 · Cited by 125
Shin, C. S., Hong, M. S., Bae, C. S., & Lee, J. (1997) · Biotechnology Progress · doi:10.1021/bp970018m · Cited by 119
Bacterial cell factories for recombinant protein production; expanding the catalogue
Ferrer‐Miralles, N., & Villaverde, A. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-113 · Cited by 119
What's fueling the biotech engine?
Aggarwal, S. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1097 · Cited by 118
Kurtzhals, P., Havelund, S., Jonassen, I., & Markussen, J. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9701768 · Cited by 117
Modifications of therapeutic proteins: challenges and prospects
Jenkins, N. (2007) · Cytotechnology · doi:10.1007/s10616-007-9075-2 · Cited by 109
Role of molecular chaperones in inclusion body formation
Carrió, M., & Villaverde, A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00126-1 · Cited by 108
Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris
Mansur, M., Cabello, C., Hern�ndez, L., Pa�s, J., Varas, L. A., Vald�s, J., Terrero, Y., Hidalgo, A., Plana, L., Besada, V., et al. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-1007-7 · Cited by 99
Kang, S., CREAGH, F. M., Peters, J. R., Brange, J., Vølund, A., & Owens, D. R. (1991) · Diabetes Care · doi:10.2337/diacare.14.7.571 · Cited by 88
What's fueling the biotech engine—2010 to 2011
Aggarwal, S. (2011) · Nature Biotechnology · doi:10.1038/nbt.2060 · Cited by 79
Sales of biologics to show robust growth through to 2013
Goodman, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3040 · Cited by 77
N-Linked Glycosylation of Antibody Fragments in Escherichia coli
Lizak, C., Fan, Y., Weber, T. C., & Aebi, M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100511k · Cited by 69
Pandhal, J., Ow, S. Y., Noirel, J., & Wright, P. C. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.23011 · Cited by 56
Sørensen, H. P., Sperling‐Petersen, H. U., & Mortensen, K. K. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00689-x · Cited by 55
Dictyostelium discoideum —a promising expression system for the production of eukaryotic proteins
Arya, R., Bhattacharya, A., & Saini, K. S. (2008) · The FASEB Journal · doi:10.1096/fj.08-110544 · Cited by 52
Self-citationYanagita, M., Nakayama, K., & Takeuchi, T. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81366-t · Cited by 51
Evaluation of bottlenecks in proinsulin secretion by Escherichia coli
Mergulhão, F. J., Taipa, M. Â., Cabral, J. M. S., & Monteiro, G. A. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2003.10.024 · Cited by 46
Production of Monoclonal Antibodies in E. coli
Reilly, D. E., & Yansura, D. G. (2009) · Springer eBooks · doi:10.1007/978-0-387-76643-0_17 · Cited by 27
Chance, R. E., Glazer, N. B., & Wishner, K. L. (1999) · Springer eBooks · doi:10.1007/978-94-017-0926-2_6 · Cited by 24
Review: Pharmacology of insulin
Ahmad, B. N. (2004) · The British Journal of Diabetes · doi:10.1177/14746514040040010201 · Cited by 19
Cited by
A Review of the Microbial Production of Bioactive Natural Products and Biologics
Pham, J. V., Yilma, M. A., Feliz, A., Majid, M. T., Maffetone, N., Walker, J. R., Kim, E., Cho, H. J., Reynolds, J. M., Song, M. C., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01404 · Cited by 565
Recombinant pharmaceuticals from microbial cells: a 2015 update
Sanchez-Garcia, L., Martín, L., Mangues, R., Ferrer-Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 339
Comparison of Yeasts as Hosts for Recombinant Protein Production
Vieira Gomes, A. M., Souza Carmo, T., Silva Carvalho, L., Mendonça Bahia, F., & Parachin, N. S. (2018) · Microorganisms · doi:10.3390/microorganisms6020038 · Cited by 308
Zaykov, A. N., Mayer, J. P., & DiMarchi, R. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.36 · Cited by 287
Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins
Schillberg, S., Raven, N., Spiegel, H., Rasche, S., & Buntru, M. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00720 · Cited by 261
Metadata
- Authors
- Baeshen, N. A., Baeshen, M. N., Sheikh, A., Bora, R. S., Ahmed, M. M. M., Ramadan, H. A. I., Saini, K. S., & Redwan, E. M.
- Venue
- Microbial Cell Factories
- Published
- 2014-10-02
- Volume
- 13
- Issue
- 1
- Pages
- 141-141
- ISSN
- 1475-2859 (ISSN-L)
- OpenAlex
- W2153492724
- Cited by
- 359
- References
- 69
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.